Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine Dose Comparison for Secondary Prevention After Acute Ischemic Stroke
ChiCTR-IPR-15007651Phase 4Recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluoxetine in ischemic stroke (2 arms), sponsored by Shenzhen People's Hospital. Started Dec 2015; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPR-15007651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007651.